Your browser doesn't support javascript.
loading
Immune microenvironment characteristics and their implications for immune checkpoint inhibitor efficacy in HER2-overexpressing gastric cancer.
Cen, Shuyi; Xu, Haimiao; Liu, Zhen; Zhao, Rongjie; Pan, Hongming; Han, Weidong.
Afiliação
  • Cen S; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Xu H; Department of Pathology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, Zhejiang, People's Republic of China.
  • Liu Z; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Zhao R; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Pan H; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Han W; Department of Medical Oncology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Clin Exp Immunol ; 207(3): 318-328, 2022 05 12.
Article em En | MEDLINE | ID: mdl-35553632
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Inibidores de Checkpoint Imunológico Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2022 Tipo de documento: Article